^
Invivoscribe's FLT3 ITD MRD Assay includes 24 unique dual-indices enabling the ability to multiplex multiple samples. This kit configuration provides laboratories the flexibility to scale testing for variable AML MRD research needs. Unlike flow cytometry assays which require fresh sample and are highly subjective, the FLT3 ITD MRD Assay, a targeted, deep sequencing assay can be used with previously isolated DNA to detect ITD mutations at an allelic sensitivity level of 5x10-5.
Cancer:
Acute Myelogenous Leukemia
Gene:
FLT3 (Fms-related tyrosine kinase 3)
Method:
Next-Generation Sequencing (NGS)